Clinical Trials in Basel, Switzerland
5 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC1,200 enrolled257 locationsNCT06312176
Recruiting
Not Applicable
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
Breast Cancer
ARTIDIS AG2,706 enrolled5 locationsNCT06085833
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Hoffmann-La Roche450 enrolled210 locationsNCT06790693
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Pilot Observational Study of an Integrative Cure Stay Program
Breast CancerGynecologic Cancer
University Hospital, Basel, Switzerland30 enrolled1 locationNCT07398079
Recruiting
Not Applicable
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Breast Cancer
University Hospital, Basel, Switzerland1,060 enrolled36 locationsNCT07140172
Recruiting
Not Applicable
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
Lymphedema, Breast Cancer
University Hospital, Basel, Switzerland280 enrolled35 locationsNCT05890677
Recruiting
Phase 2
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
Swiss Cancer Institute54 enrolled9 locationsNCT06358573
Recruiting
Not Applicable
Quality of Life Improvement During Chemotherapy
Breast Cancer FemaleChemotherapy Effect
Christian Schwegler62 enrolled1 locationNCT04694885
Recruiting
Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
AstraZeneca5,500 enrolled794 locationsNCT05952557
Recruiting
Early Pulmonary Dysfunction in Childhood Cancer Patients
Pulmonary Dysfunction
University Children's Hospital Basel140 enrolled5 locationsNCT05427136
Recruiting
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
Hereditary Breast and Ovarian CancerLynch Syndrome
University of Basel700 enrolled9 locationsNCT03124212
Recruiting
Not Applicable
The DIALOGUE Study: Swiss-Korean Billateral Collaboration
Breast CancerOvarian CancerHereditary Cancer
University of Basel228 enrolled8 locationsNCT04214210
Recruiting
An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol
Breast CancerLymphedema
University Hospital, Basel, Switzerland500 enrolled1 locationNCT06374745
Recruiting
Not Applicable
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
Node-positive Breast Cancer
University Hospital, Basel, Switzerland1,500 enrolled67 locationsNCT03513614
Recruiting
Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
CarcinomaNon-Small-Cell Lung
AstraZeneca324 enrolled283 locationsNCT05261399
Recruiting
Not Applicable
Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer
Breast Cancer
Klinik Hirslanden, Zurich420 enrolled26 locationsNCT04289935